A randomized, controlled trial to compare the efficacy and safety profile of a dexmedetomidine-ketamine combination with a propofol-fentanyl combination for ERCP

Published:September 10, 2015DOI:

      Background and Aims

      Moderate to deep levels of sedation and analgesia are required for ERCP. Propofol-based sedation is simple, easy to use, and effective, but is not without cardiovascular and respiratory adverse effects. The combination of dexmedetomidine and ketamine (DK) has shown promising results for sedation in other similar scenarios. The aim of this study was to compare the efficacy and safety of a standard propofol-fentanyl (PF) regimen with a DK combination.


      After approval of the hospital ethics committee, 83 patients (18-75 years of age) were randomized and divided into 2 groups. Forty-two patients received a PF combination (group PF) and 41 patients received DK combination (group DK) for total intravenous anesthesia for ERCP as initial boluses followed by an infusion of PF and DK, respectively. The sedation-related adverse effects and recovery time were noted.


      The mean values of the hemodynamic and respiratory parameters were in clinically acceptable ranges, but there were more episodes of hypotension (19%), bradycardia (4.7%), and decrease in oxygen saturation (Spo2 <80% in 11.9% and Spo2 <90% for >10 s in 42.8%) in group PF. The procedure could be completed in all of the patients but was interrupted in 6 patients in group PF because of desaturation (5) or sudden patient movement (1). The recovery time was longer in group DK than in group PF.


      There were significantly fewer sedation-related adverse effects, but the recovery time was longer with DK.


      DK (dexmedetomidine and ketamine), HR (heart rate), MAP (mean arterial pressure), PF (propofol and fentanyl), Spo2 (oxygen saturation)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Dumonceau J.M.
        • Riphaus A.
        • Aparicio J.R.
        • et al.
        • NAAP Task Force Members
        European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: non-anesthesiologist administration of propofol for GI endoscopy.
        Endoscopy. 2010; 42: 960-974
        • Lichtenstein D.R.
        • Jagannath S.
        • Baron T.H.
        • et al.
        Sedation and anesthesia in GI endoscopy.
        Gastrointest Endosc. 2008; 68: 815-826
      1. American Society of Anesthesiologists (ASA). Statement on safe use of propofol. Committee of origin: ambulatory surgical care (Approved by the ASA House of Delegates on 27 October 2004, and amended on 21 October 2009). Available at: http://www.asahq. Accessed May 5, 2015.

      2. The Joint Royal Colleges of Anaesthetists (RCoA) and British Society of Gastroenterology (BSG) Working Party. Guidance for the use of propofol sedation for adult patients undergoing Endoscopic Retrograde Cholangiopancreatography (ERCP) and other complex upper GI endoscopic procedures. April 2011 (Approved on March 2014). Available at: Accessed May 5, 2015.

      3. Department of Health and Human Services. “Petition denial for request for removal of warning of labeling for Diprivan (propofol),” Docket no FDA-2005-P-0059, August 2010. Available at: http://www.asahq. Accessed May 5, 2015.

        • Tyler M.B.
        • Sanaka S.
        • Barnett S.R.
        • et al.
        A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation.
        Gastrointest Endosc. 2011; 73: 710-717
        • Goyal R.
        • Singh S.
        • Shukla R.N.
        • et al.
        Ketodex, a combination of dexmedetomidine and ketamine for upper gastrointestinal endoscopy in children: a preliminary report.
        J Anesth. 2013; 27: 461-463
        • Ramsay M.A.
        • Savege T.M.
        • Simpson B.R.
        • et al.
        Controlled sedation with alphaxalone-alphadolone.
        Br Med J. 1974; 2: 656-659
        • Aldrete J.A.
        The post anaesthesia recovery score revisited [letter].
        J Clin Anesth. 1995; 7: 89-91
        • Fabbri L.P.
        • Nucera M.
        • Marsili M.
        • et al.
        Ketamine, propofol and low dose remifentanil versus propofol and remifentanil for ERCP outside the operating room: is ketamine not only a ‘rescue drug’?.
        Med Sci Monit. 2012; 18: 575-580
        • Raymondos K.
        • Panning B.
        • Bachem I.
        Evaluation of endoscopic retrograde cholangiopancreatography under conscious sedation and general anesthesia.
        Endosc. 2002; 34: 721-726
        • Laurie T.
        • Chang G.L.
        • Hammerman S.
        • et al.
        Comparison of anesthesia associated (AA) sedation with conscious sedation (CS) in successful completion of endoscopic retrograde cholangiopancreatography [abstract].
        Gastrointest Endosc. 2005; 61: AB118
        • Coté G.
        • Hovis R.
        • Ansstas M.
        Incidence of sedation-related complications with propofol use during advanced endoscopic procedures.
        Clin Gastroenterol Hepatol. 2010; 8: 137-142
        • Berzin T.
        • Sanaka S.
        • Barnett S.
        A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist administered sedation.
        Gastrointest Endosc. 2011; 73: 710-717
        • Wani S.
        • Azar R.
        • Hovis C.E.
        Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures.
        Gastrointest Endosc. 2011; 74: 1238-1247
        • Lordan J.
        • Woods J.
        • Keeling P.
        A retrospective analysis of benzodiazepine sedation vs. propofol anaesthesia in 252 patients undergoing endoscopic retrograde cholangiopancreatography.
        HPB. 2011; 13: 174-177
        • Garewal D.
        • Vele L.
        • Waikar P.
        Anaesthetic considerations for endoscopic retrograde cholangio-pancreatography procedures.
        Curr Opin Anesthesiol. 2013; 26: 475-480
        • Jalowiecki P.
        • Rudner R.
        • Gonciarz M.
        Sole use of dexmedetomidine has limited utility for conscious sedation during out- patient colonoscopy.
        Anesthesiology. 2005; 103: 269-273
        • Tobias J.D.
        Dexmedetomidine and ketamine: an effective alternative for procedural sedation?.
        Pediatr Crit Care Med. 2012; 13: 423-427
        • Levänen J.
        • Mäkelä M.L.
        • Scheinin H.
        Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium.
        Anesthesiology. 1995; 82: 1117-1125
        • Dawes J.
        • Myers D.
        • Gorges M.
        • et al.
        Identifying a rapid bolus dose of dexmedetomidine (ED50) with acceptable hemodynamic outcomes in children.
        Pediatr Anaesth. 2014; 24: 1260-1267
        • American Society for Gastrointestinal Endoscopy
        Sedation and anesthesia in GI endoscopy.
        Gastrointest Endosc. 2008; 68: 815-826
        • Qadeer M.A.
        • Vargo J.J.
        • Dumot J.A.
        Capnographic monitoring of respiratory activity improves safety of sedation for endoscopic cholangicreatography and ultrasonography.
        Gastroenterology. 2009; 136: 1568-1576
        • Von Delius S.
        • Salletmaier H.
        • Meining A.
        Bispectral index monitoring of midazolam and propofol sedation during endoscopic retrograde cholangiopancreatography: a randomized clinical trial (the EndoBIS study).
        Endoscopy. 2012; 44: 258-264
        • Amornyotin S.
        • Chalayonnavin W.
        • Kongphlay S.
        Deep sedation for endoscopic retrograde cholangiopancreatography: a comparison between clinical assessment and Narcotrend monitoring.
        Med Devices (Auckl). 2011; 4: 43-49
        • Jang S.Y.
        • Park H.G.
        • Jung M.K.
        • et al.
        Bispectral index monitoring as an adjunct to nurse-administered combined sedation during endoscopic retrograde cholangiopancreatography.
        World J Gastroenterol. 2012; 18: 6284-6289
        • Mukhopadhyay S.
        • Niyogi M.
        • Sarkar J.
        • et al.
        The dexmedetomidine “augmented” sedatoanalgesic cocktail: an effective approach for sedation in prolonged endoscopic retrograde cholangiopancreatography.
        J Anaesthesiol Clin Pharmacol. 2015; 31: 201-206